Trials / Terminated
TerminatedNCT00417833
Multifocal Electrophysiologic Findings After Intravitreal Bevacizumab(Avastin)Treatment
- Status
- Terminated
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Asociación para Evitar la Ceguera en México · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- —
Summary
Purpose: Determine the short-term safety of intravitreal bevacizumab by multifocal electroretinography (mf-ERG). Methods: 120 eyes with choroidal neovascularization, proliferative diabetic retinopathy and retinal vein occlusion received intravitreal bevacizumab (2.5mg/0.1cc). All patients underwent best corrected visual acuity, fluorescein angiography, optical coherent tomography and mf-ERG before and 1 month after treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Intravitreal Bevacizumab |
Timeline
- Start date
- 2005-12-01
- Completion
- 2006-07-01
- First posted
- 2007-01-04
- Last updated
- 2024-06-03
Source: ClinicalTrials.gov record NCT00417833. Inclusion in this directory is not an endorsement.